English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Evaluation of Coronary Risk Score Applications in 10-Year Coronary Heart Risk Estimation Atherosclerosis is a multifactorial disease with risk factors that have multiple effects. In the identification and treatment of asymptomatic individuals at high risk for developing coronary heart disease (CHD) different risk scoring schemes are used in everyday routine. The aim of this study was to compare SCORE recommended for our country with two other most frequently used risk schemes for 10-year CHD risk evaluation: Framingham and PROCAM as well as their modifications. From 220 examined subjects of both sexes, who were treated mainly for lipid metabolism disorder at the Dispensary for Atherosclerosis Prevention, Centre for Laboratory Medicine, Clinical Centre of Vojvodina, 110 subjects were included in our study and agreed to a one-year follow-up. At first check-up, 15% had low risk according to Framingham Weibull and 78% according to PROCAM, intermediate 12% according to PROCAM NS up to 45% according to Framingham Weibull, and high 8% according to PROCAM up to 40% according to Framingham Weibull. After a one-year treatment 30% were in the low risk category according to Framingham Weibull and 88% according to PROCAM. Intermediate from 10% according to PROCAM to 36% according to Framingham Weibull, and high from 2% according to PROCAM to 25% according to Framingham Weibull. There is a significantly lower percentage of high risk individuals and a higher percentage of low risk individuals after one year of lipid disorder treatment. Ispitivanje Značaja Primene Bodovnih Sistema za Procenu Ukupnog 10-Godišnjeg Rizika za Koronarnu Bolest Srca S obzirom na to da je ateroskleroza multifaktorijalna bolest, u cilju identifikacije i lečenja asimptomatskih osoba s visokim rizikom za razvoj koronarne bolesti srca (KBS) u praksi se koriste različiti bodovni sistemi za procenu rizika. Cilj ovog istraživanja je da se izvrši upoređivanje SCORE bodovnog sistema preporučenog za našu sredinu sa ostala dva najčešće korišćena bodovna sistema za procenu 10-godišnjeg rizika za KBS: Framinghamskog i PROCAM sistema, kao i njihovih modifikacija. Od 220 pregledanih ispitanika oba pola, upućenih u Ambulantu za prevenciju ateroskleroze Kliničkog centra Vojvodine prvenstveno radi lečenja lipidskog poremećaja, 110 je uključeno u našu studiju i praćeno godinu dana. Prilikom prvog pregleda, osoba s niskim rizikom je bilo od 15% prema skoru Framingham Weibull do 78% prema skoru PROCAM, srednjim od 12% prema PROCAM NS do 45% prema Framingham Weibullu, a visokim od 8% prema PROCAM-u do 40% prema Framigham Weibullu. Posle godinu dana lečenja, u kategoriji niskog rizika bilo je od 30% prema Framingham Weibullu do 88% prema PROCAM-u, srednjeg od 10% prema PROCAM-u do 36% prema Framingham Weibullu, a visokog od 2% prema PROCAM-u do 25% prema Framingham Weibullu. Kako su lipidski parametri značajni kriterijumi svih bodovnih sistema za procenu rizika od KBS, ustanovljeno je očekivano signifikantno sniženje broja ispitanika u kategoriji visokog, a povećanje u kategoriji niskog rizika posle godinu dana lečenja lipidskog poremećaja, procenjivano prema svim ispitivanim bodovnim sistemima.